| 2024-03-14 | Sale | Neurocrine Biosciences, Inc. NBIX | director | 40,000 0.0396% | $139.42 | $5.58M | -0.97% | |
| 2021-08-02 | Sale | Align Technology, Inc. ALGN | director | 5,000 0.0064% | $707.34 | $3.54M | -27.55% | |
| 2021-02-08 | Sale | Align Technology, Inc. ALGN | director | 15,000 0.0197% | $624.60 | $9.37M | +1.51% | |
| 2020-11-04 | Sale | Align Technology, Inc. ALGN | director | 5,000 0.0063% | $480.03 | $2.4M | +23.18% | |
| 2020-10-26 | Sale | Align Technology, Inc. ALGN | director | 17,273 0.0225% | $465.62 | $8.04M | +30.56% | |
| 2016-05-23 | Sale | Align Technology, Inc. ALGN | director | 50,000 0.0628% | $77.72 | $3.89M | +21.85% | |
| 2013-10-22 | Sale | Align Technology, Inc. ALGN | director | 75,000 0.0934% | $57.27 | $4.3M | -4.38% | |
| 2009-06-09 | Sale | Amgen Inc. AMGN | Exe VP, Global Commercial Ops | 21,000 0.0021% | $51.07 | $1.07M | +13.16% | |
| 2008-10-24 | Sale | Amgen Inc. AMGN | Exe VP, Global Commercial Ops | 57,394 0.0036% | $38.36 | $2.2M | -0.56% | |
| 2008-05-15 | Align Technology, Inc. ALGN | director | 10,000 0.0143% | $12.63 | $126,277 | -28.39% | ||
| 2007-12-07 | Amgen Inc. AMGN | Exe VP, Global Commercial Ops | 2,025.42 0.0002% | $69.97 | $141,719 | -8.71% | ||
| 2005-07-25 | Sale | Amgen Inc. AMGN | Exe VP, Global Commercial Ops | 303,335 0.0246% | $81.15 | $24.62M | -7.31% | |
| 2004-11-23 | Sale | Amgen Inc. AMGN | Exe VP, Global Commercial Ops | 59,998 0.0047% | $59.57 | $3.57M | +5.5% | |
| 2000-10-26 | Sale | Align Technology, Inc. ALGN | director | 5,454 0.4513% | $468.78 | $2.56M |